These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3283410)

  • 1. Interleukin-1 and its relevance in patients treated with hemodialysis.
    Dinarello CA; Koch KM; Shaldon S
    Kidney Int Suppl; 1988 Mar; 24():S21-6. PubMed ID: 3283410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytokines on hemodialysis].
    Yamagami S
    Nihon Rinsho; 1992 Jan; 50 Suppl():643-50. PubMed ID: 1578748
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes.
    Lonnemann G; Bingel M; Koch KM; Shaldon S; Dinarello CA
    Lymphokine Res; 1987; 6(2):63-70. PubMed ID: 3495707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The link between dialysate and chronic inflammatory disease in hemodialysis.
    Amato RL
    Nephrol Nurs J; 2002 Oct; 29(5):490-2. PubMed ID: 12434456
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin in patients with terminal renal failure undergoing dialysis with re-processing dialyser.
    Markum HM; Suhardjono ; Pohan HT; Suhendro ; Lydia A; Inada K
    Acta Med Indones; 2004; 36(2):93-6. PubMed ID: 15931701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of serum IgE levels on eosinophilia of patients in hemodialysis].
    Montoliu J; Vives A; López-Pedret J; Revert L
    Med Clin (Barc); 1983 Oct; 81(13):567-8. PubMed ID: 6656382
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-1 and dialysis.
    Shaldon S; Dinarello CA; Koch KM; Lonnemann G; Bingel M; Granolleras C; Deschodt G; Branger B; Oulès R; Fourcade J
    Adv Nephrol Necker Hosp; 1988; 17():423-34. PubMed ID: 3124551
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of lipopolysaccharide-induced interleukin-1 production by human monocytes. Clinical relevance in patients undergoing hemodialysis.
    Haeffner-Cavaillon N; Bacle F; Caroff M; Cavaillon JM
    Prog Clin Biol Res; 1988; 272():89-101. PubMed ID: 3260673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histidine in the treatment of anemia in patients with chronic renal failure treated by hemodialysis].
    Rutkowski B; Góra E; Barlik J; Manitius J; Jakubowski Z
    Pol Tyg Lek; 1987 Aug; 42(34):1031-4. PubMed ID: 3422836
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic alterations associated with chronic hemodialysis.
    Rus HG; Cristea A; Gherman M; Niculescu F; Gavan M
    Med Interne; 1983; 21(4):289-95. PubMed ID: 6658343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 stimulation in the ESRD patient: potential long-term consequences.
    Shaldon S; Elie M; Koch KM; Dinarello CA
    Transplant Proc; 1987 Oct; 19(5):4353-7. PubMed ID: 3118543
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of hemodialysis on the coagulo-lytic system of chronic kidney failure patients].
    Follana R; Salvadori JM; Sampol J; Olmer M
    J Urol Nephrol (Paris); 1973; 79(4):367-9. PubMed ID: 4720129
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic and conservative treatment of arteriovenous shunts in chronic kidney disease patients treated with periodic hemodialysis].
    Ancona G
    Chir Patol Sper; 1966; 14(7):246-65. PubMed ID: 5990179
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood requirement and subtotal parathyroidectomy in patients with chronic renal failure treated with hemodialysis.
    Szücs J; Makó J; Mérey J
    Clin Nephrol; 1983 Mar; 19(3):134-6. PubMed ID: 6839563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute pericarditis in chronic renal failure treated with repeated hemodialysis].
    Meyrier A; Leroux-Robert C; Sraer JD; Marsac J; Richet G
    Ann Chir Thorac Cardiovasc; 1972 Apr; 11(2):201-6. PubMed ID: 5036854
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidized immunoglobulin G in patients with end-stage renal disease treated by hemodialysis.
    Ahmed S; Gibbons N; Mattana J
    Ann Clin Lab Sci; 2003; 33(1):11-7. PubMed ID: 12661893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.